Search research articles
Contact Us
Filters
Showing results (101-110 of 124) with videos related to
Page
of 13
Sort By:
Leukemia & Lymphoma
|
October 15, 2015
Dose-reduced fludarabine, cyclophosphamide and rituximab is well tolerated in older patients with chronic lymphocytic leukemia and has preserved therapeutic efficacy
Thomas E Lew, Chan Y Cheah, Dennis A Carney, et al.
Blood
|
May 6, 2017
Clinicopathological features and outcomes of progression of CLL on the BCL2 inhibitor venetoclax
Mary Ann Anderson, Constantine Tam, Thomas E Lew, et al.
International Journal for Parasitology
|
December 20, 2011
CattleTickBase: an integrated Internet-based bioinformatics resource for Rhipicephalus (Boophilus) microplus
Matthew I Bellgard, Paula M Moolhuijzen, Felix D Guerrero, et al.
Blood
|
April 4, 2020
BTK inhibitor therapy is effective in patients with CLL resistant to venetoclax
Victor S Lin, Thomas E Lew, Sasanka M Handunnetti, et al.
Blood Advances
|
January 15, 2020
Undetectable peripheral blood MRD should be the goal of venetoclax in CLL, but attainment plateaus after 24 months
Thomas E Lew, Mary Ann Anderson, Victor S Lin, et al.
Veterinary Parasitology
|
October 20, 2009
Suppressive subtractive hybridization analysis of Rhipicephalus (Boophilus) microplus larval and adult transcript expression during attachment and feeding
Ala E Lew-Tabor, Paula M Moolhuijzen, Megan E Vance, et al.
Molecular and Cellular Probes
|
January 15, 2009
Real-time polymerase chain reaction (PCR) assays for the specific detection and quantification of seven Eimeria species that cause coccidiosis in chickens
J A T Morgan, G M Morris, B M Wlodek, et al.
Journal of Thrombosis and Thrombolysis
|
September 27, 2008
Intracoronary pharmacotherapy in the management of coronary microvascular dysfunction
Vijayalakshmi Kunadian, Cafer Zorkun, Scott P Williams, et al.
Blood Advances
|
July 28, 2022
Enrichment of BTK Leu528Trp mutations in patients with CLL on zanubrutinib: potential for pirtobrutinib cross-resistance
Piers Blombery, Ella R Thompson, Thomas E Lew, et al.
Blood Advances
|
September 3, 2021
Outcomes of patients with CLL sequentially resistant to both BCL2 and BTK inhibition
Thomas E Lew, Victor S Lin, Edward R Cliff, et al.
Page
of 13
Search research articles
Search
Showing results (101-110 of 124) with videos related to
Sort By:
Page
of 13
Leukemia & Lymphoma
|
October 15, 2015
Dose-reduced fludarabine, cyclophosphamide and rituximab is well tolerated in older patients with chronic lymphocytic leukemia and has preserved therapeutic efficacy
Thomas E Lew, Chan Y Cheah, Dennis A Carney, et al.
Blood
|
May 6, 2017
Clinicopathological features and outcomes of progression of CLL on the BCL2 inhibitor venetoclax
Mary Ann Anderson, Constantine Tam, Thomas E Lew, et al.
International Journal for Parasitology
|
December 20, 2011
CattleTickBase: an integrated Internet-based bioinformatics resource for Rhipicephalus (Boophilus) microplus
Matthew I Bellgard, Paula M Moolhuijzen, Felix D Guerrero, et al.
Blood
|
April 4, 2020
BTK inhibitor therapy is effective in patients with CLL resistant to venetoclax
Victor S Lin, Thomas E Lew, Sasanka M Handunnetti, et al.
Blood Advances
|
January 15, 2020
Undetectable peripheral blood MRD should be the goal of venetoclax in CLL, but attainment plateaus after 24 months
Thomas E Lew, Mary Ann Anderson, Victor S Lin, et al.
Veterinary Parasitology
|
October 20, 2009
Suppressive subtractive hybridization analysis of Rhipicephalus (Boophilus) microplus larval and adult transcript expression during attachment and feeding
Ala E Lew-Tabor, Paula M Moolhuijzen, Megan E Vance, et al.
Molecular and Cellular Probes
|
January 15, 2009
Real-time polymerase chain reaction (PCR) assays for the specific detection and quantification of seven Eimeria species that cause coccidiosis in chickens
J A T Morgan, G M Morris, B M Wlodek, et al.
Journal of Thrombosis and Thrombolysis
|
September 27, 2008
Intracoronary pharmacotherapy in the management of coronary microvascular dysfunction
Vijayalakshmi Kunadian, Cafer Zorkun, Scott P Williams, et al.
Blood Advances
|
July 28, 2022
Enrichment of BTK Leu528Trp mutations in patients with CLL on zanubrutinib: potential for pirtobrutinib cross-resistance
Piers Blombery, Ella R Thompson, Thomas E Lew, et al.
Blood Advances
|
September 3, 2021
Outcomes of patients with CLL sequentially resistant to both BCL2 and BTK inhibition
Thomas E Lew, Victor S Lin, Edward R Cliff, et al.
Page
of 13